N

Anbio Biotechnology
D

NNNN

16.010
USD
4.35
(37.31%)
مغلق
حجم التداول
11,802
الربح لكل سهم
0
العائد الربحي
-
P/E
296
حجم السوق
702,698,112
المقالات

العنوان: Anbio Biotechnology

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.